These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 37829757)
1. Expression of nectin-4 in prostate cancer. Ordu M; Karaaslan M; Sirin ME; Yilmaz M North Clin Istanb; 2023; 10(5):583-588. PubMed ID: 37829757 [TBL] [Abstract][Full Text] [Related]
2. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Zhou M; Aydin H; Kanane H; Epstein JI Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314 [TBL] [Abstract][Full Text] [Related]
3. T2E (TMPRSS2-ERG) fusion transcripts are associated with higher levels of AMACR mRNA and a subsequent prostate cancer diagnosis in patients with atypical small acinar proliferation. Eryilmaz IE; Kordan Y; Vuruskan BA; Kaygısız O; Tunca B; Cecener G Gene; 2018 Mar; 645():69-75. PubMed ID: 29277318 [TBL] [Abstract][Full Text] [Related]
4. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Zhou M; Jiang Z; Epstein JI Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580 [TBL] [Abstract][Full Text] [Related]
5. Age-associated changes in alpha-methyl CoA racemase (AMACR) expression in nonneoplastic prostatic tissues. Gologan A; Bastacky S; McHale T; Yu J; Cai C; Monzon-Bordonaba F; Dhir R Am J Surg Pathol; 2005 Nov; 29(11):1435-41. PubMed ID: 16224209 [TBL] [Abstract][Full Text] [Related]
6. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890 [TBL] [Abstract][Full Text] [Related]
7. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer. Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744 [TBL] [Abstract][Full Text] [Related]
8. Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements. Rubin MA; Zerkowski MP; Camp RL; Kuefer R; Hofer MD; Chinnaiyan AM; Rimm DL Am J Pathol; 2004 Mar; 164(3):831-40. PubMed ID: 14982837 [TBL] [Abstract][Full Text] [Related]
10. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression. Warrick JI; Humphrey PA Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726 [TBL] [Abstract][Full Text] [Related]
11. RNA-based markers in biopsy cores with atypical small acinar proliferation: Predictive effect of T2E fusion positivity and MMP-2 upregulation for a subsequent prostate cancer diagnosis. Eryilmaz IE; Aytac Vuruskan B; Kaygısız O; Egeli U; Tunca B; Kordan Y; Cecener G Prostate; 2019 Feb; 79(2):195-205. PubMed ID: 30294801 [TBL] [Abstract][Full Text] [Related]
12. Pathologic results of radical prostatectomies in patients with simultaneous atypical small acinar proliferation and prostate cancer. Kim KH; Kim YB; Lee JK; Kim YJ; Jung TY Korean J Urol; 2010 Jun; 51(6):398-402. PubMed ID: 20577606 [TBL] [Abstract][Full Text] [Related]
13. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Magi-Galluzzi C; Luo J; Isaacs WB; Hicks JL; de Marzo AM; Epstein JI Am J Surg Pathol; 2003 Aug; 27(8):1128-33. PubMed ID: 12883245 [TBL] [Abstract][Full Text] [Related]
14. 34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts. Pierconti F; Rossi ED; Martini M; Sacco E; Bassi PF; Larocca LM Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):306-310. PubMed ID: 29346181 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate. Herawi M; Epstein JI Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076 [TBL] [Abstract][Full Text] [Related]
17. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy. Farinola MA; Epstein JI Hum Pathol; 2004 Oct; 35(10):1272-8. PubMed ID: 15492996 [TBL] [Abstract][Full Text] [Related]
18. Atypical small acinar proliferation and two or more cores of high-grade intraepithelial neoplasia on a previous prostate biopsy are significant predictors of cancer during a transperineal template-guided saturation biopsy aimed at sampling one core for each 1 mL of prostate volume. Nakai Y; Tanaka N; Miyake M; Hori S; Tatsumi Y; Morizawa Y; Fujii T; Konishi N; Fujimoto K Res Rep Urol; 2017; 9():187-193. PubMed ID: 29034221 [TBL] [Abstract][Full Text] [Related]
19. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment? Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995 [TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens. Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]